| (19) |
 |
|
(11) |
EP 0 957 110 A3 |
| (12) |
EUROPEAN PATENT APPLICATION |
| (88) |
Date of publication A3: |
|
14.08.2002 Bulletin 2002/33 |
| (43) |
Date of publication A2: |
|
17.11.1999 Bulletin 1999/46 |
| (22) |
Date of filing: 10.05.1999 |
|
|
| (84) |
Designated Contracting States: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
Designated Extension States: |
|
AL LT LV MK RO SI |
| (30) |
Priority: |
14.05.1998 US 85382 P
|
| (71) |
Applicant: Cytoskeleton, Inc. |
|
Denver,CO 80206 (US) |
|
| (72) |
Inventors: |
|
- Middleton, Kim Ph.D., c/o Cytoskeleton, Inc.
Denver, CO 80206 (US)
- Ashley, Davis Ph.D., c/o Cytoskeleton, Inc.
Denver, CO 80206 (US)
|
| (74) |
Representative: Lee, Nicholas John |
|
Kilburn & Strode, 20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB) |
|
| |
|
| (54) |
Lyophilized tubulins |
(57) Lyophilized active tubulin and numerous uses of lyophilized active tubulin such as
diagnostic, therapeutic, drug discovery, and research applications are provided. The
process of making the lyophilized active tubulin is also described.